Indication
Post-Traumatic Stress Disorder
104 clinical trials
94 products
3 drugs
Clinical trial
Retrospective Review of Ketamine Assisted Psychotherapy Program on Mental Health at Field Trip Health Centres in North AmericaStatus: Completed, Estimated PCD: 2022-06-16
Clinical trial
Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2008-05-02
Product
MidomafetamineClinical trial
A Pilot Study to Assess the Use of Methylone in the Treatment of PTSD IMPACT-1 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])Status: Recruiting, Estimated PCD: 2024-12-01
Product
MethyloneClinical trial
A First-in-human, Randomized, Double-blinded, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability and Food-effects of EA1080 in Healthy Caucasian and Japanese Male VolunteersStatus: Completed, Estimated PCD: 2023-08-06
Product
PlaceboProduct
Lactose placeboClinical trial
An Open-Label Proof-of-Principle Study Testing the Use of an Additional MDMA-Assisted Therapy Session in People Who Relapsed After Participating in a Phase 2 Clinical Trial of MDMA-Assisted Therapy to Treat Chronic, Treatment-Resistant Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2014-06-27
Product
JZP150Clinical trial
A Multicenter Phase 2, 12-week Double-blind, Placebo-controlled, Randomized, Parallel-group Study of JZP150 for the Treatment of Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2023-12-05
Clinical trial
A Randomized, Double-Blind, Dose Response Phase 2 Pilot Study of Manualized MDMA-Assisted Psychotherapy in Subjects With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2015-12-03
Product
Active Dose 2 MDMAClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2020-08-11
Product
MDMAClinical trial
Exploring Mechanisms of Action of ±3,4-methylenedioxymethamphetamine (MDMA)- Assisted Psychotherapy for Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2015-08-03
Clinical trial
Phase II Clinical Trial Testing the Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Chronic Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2008-05-02
Product
LactoseClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder of Moderate or Greater SeverityStatus: Completed, Estimated PCD: 2022-10-30
Clinical trial
A Phase 1/2 Open-Label Treatment Development Study of Methylenedioxymethamphetamine (MDMA)-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2017-12-16
Product
Comparative-dose MDMAProduct
Active Dose 1 MDMAClinical trial
A Phase 2, Open Label Study of the Safety and Effectiveness of MDMA-assisted Therapy for Participants With Posttraumatic Stress DisorderStatus: Withdrawn, Estimated PCD: 2023-08-01
Product
Active Dose 1Clinical trial
An Open-Label, Multi-Site Phase 2 Study of the Safety and Effect of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder (Canada)Status: Completed, Estimated PCD: 2019-06-04
Product
Active Dose 2Clinical trial
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD IMPACT-2 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-05-04
Clinical trial
A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments With Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])Status: , Estimated PCD: 2027-05-01
Product
PsilocybinClinical trial
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderStatus: Active (not recruiting), Estimated PCD: 2023-12-19
Product
BI 1358894Clinical trial
A Phase II, 8-week-treatment, Multicenter, Randomized, Doubleblind, Placebo-controlled, Parallel Group Trial to Evaluate the Efficacy, Tolerability and Safety of Orally Administered BI 1358894 in Patients With Post-Traumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2023-10-12
Clinical trial
Randomized, Triple-Blind, Phase 2 Pilot Study Comparing 3 Different Doses of MDMA in Conjunction With Manualized Therapy in 24 Veterans, Firefighters and Police Officers With Chronic Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2015-06-04
Clinical trial
MDMA-assisted Therapy in Twelve People With War and Terrorism-related Posttraumatic Stress Disorder (PTSD)Status: Terminated, Estimated PCD: 2009-03-01
Clinical trial
A Randomized, Double-Blind, Controlled Phase 2 Pilot Study of Manualized 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in 12 Subjects With Treatment-Resistant Posttraumatic Stress Disorder (PTSD) - CanadaStatus: Terminated, Estimated PCD: 2015-09-10
Product
Full dose MDMAProduct
Active Dose 2 (100 mg) MDMAClinical trial
A Randomized Trial of MDMA-Assisted Cognitive-Behavioural Conjoint Therapy (CBCT) Versus CBCT in Dyads in Which One Member Has Posttraumatic Stress Disorder (PTSD)Status: Recruiting, Estimated PCD: 2025-12-31
Product
Lactose placebo pillProduct
Active Dose 1 (125 mg) MDMAProduct
PRAX-114Clinical trial
A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Post-Traumatic Stress DisorderStatus: Terminated, Estimated PCD: 2022-08-01
Product
ALTO-100Clinical trial
A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2023-07-25
Clinical trial
An Open-label Study of ALTO-100 in Adults With Major Depressive Disorder and/or Post-traumatic Stress DisorderStatus: Completed, Estimated PCD: 2022-12-01
Product
BrexpiprazoleProduct
SertralineClinical trial
Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress DisorderStatus: Active (not recruiting), Estimated PCD: 2023-10-30
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind Trial of Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress DisorderStatus: Completed, Estimated PCD: 2023-07-19
Product
BNC210Clinical trial
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)Status: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind Trial of Fixed-Dose Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress DisorderStatus: Completed, Estimated PCD: 2023-07-25
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase II Study of BNC210 in Adults With Post-Traumatic Stress Disorder (PTSD).Status: Completed, Estimated PCD: 2018-07-05
Clinical trial
Characterization of Comorbid Post-traumatic Stress Disorder and Major Depressive Disorder Utilizing Ketamine as an Experimental Medicine ProbeStatus: Recruiting, Estimated PCD: 2024-04-01
Drug
KetamineClinical trial
Effect of Ketamine and Etomidate During Rapid Sequence Intubation on Long- Term Outcomes (Long-Term Outcomes of the RSI Trial)Status: Recruiting, Estimated PCD: 2027-01-01
Product
EtomidateClinical trial
An Open Label, Phase 2, Single-arm Pilot Study to Investigate the Safety and Preliminary Effectiveness of MDMA-assisted Therapy in Veterans With Co-occurring Alcohol Use Disorder and Post-traumatic Stress Disorder (AUD-PTSD)Status: Recruiting, Estimated PCD: 2025-01-21
Clinical trial
Optimal Treatment of Veterans With PTSD and Comorbid Opiate Use Disorder (OUD)Status: Terminated, Estimated PCD: 2023-04-14
Product
BuprenorphineClinical trial
Phase II Pilot Randomized Double-Blind Placebo-Controlled Study of 3,4-methylenedioxymethamphetamine (MDMA)Assisted Psychotherapy in Posttraumatic Stress Disorder (PTSD)- SwitzerlandStatus: Completed, Estimated PCD: 2009-09-02
Clinical trial
Noradrenergic Biomarkers in PTSD: Precision Medicine & MechanismsStatus: Recruiting, Estimated PCD: 2024-06-28
Product
PrazosinClinical trial
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD: What Works Best, and for WhomStatus: Recruiting, Estimated PCD: 2026-02-15
Product
Paroxetine or Venlafaxine XRClinical trial
A Sequential, Multiple Assignment Randomized Trial (SMART) for Non-specialist Treatment of Common Mental Disorders in Kenya: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research (DAPPER) ProjectStatus: Completed, Estimated PCD: 2024-05-06
Product
FluoxetineClinical trial
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine ResponseStatus: Recruiting, Estimated PCD: 2032-12-01
Product
PerampanelClinical trial
The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated MemoriesStatus: Recruiting, Estimated PCD: 2023-12-31
Product
DronabinolClinical trial
A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members and Veterans With PTSDStatus: Recruiting, Estimated PCD: 2026-03-01
Product
DaridorexantProduct
Intervention CClinical trial
The Relation Between Attentional, Sensory and Emotional Dysregulation in Adults With Posttraumatic Stress Disorder: a Double-blind, Placebo-controlled Randomized Controlled Trial of the Combined Treatment With Reboxetine and MethylphenidateStatus: Recruiting, Estimated PCD: 2024-02-01
Product
MethylphenidateProduct
ReboxetineClinical trial
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With Post Traumatic Stress DisorderStatus: Recruiting, Estimated PCD: 2025-08-31
Product
TopiramateClinical trial
A Multicenter Phase II Rater-blinded Randomized Controlled Trial (RCT) to Compare Effectiveness of Eye Movement Desensitization Reprocessing Therapy (EMDR) vs Treatment as Usual (TAU) in First Episode Psychosis and History of Trauma.Status: Active (not recruiting), Estimated PCD: 2024-11-30
Product
Treatment as usualClinical trial
Examining the Efficacy and Safety of Subanesthetic Ketamine on Depression and Post-traumatic Stress Among Veterans With Mild and Moderate Traumatic Brain InjuryStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Product
KetamineProduct
MidazolamClinical trial
Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol: A Randomized Controlled Study (THC PTSD-trial)Status: Recruiting, Estimated PCD: 2025-01-01
Product
BX-1Clinical trial
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & RecoveryStatus: Not yet recruiting, Estimated PCD: 2027-09-01
Product
CannabidiolProduct
Delta-9-tetrahydrocannabinolClinical trial
Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSDStatus: Recruiting, Estimated PCD: 2024-12-01
Product
THC:CBD 1:1Product
THC:CBD 1:10Clinical trial
A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members and Veterans With PTSDStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Product
B VilazodoneProduct
Intervention BClinical trial
Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label TrialStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
Use of Cannabidiol (CBD) Oil in the Treatment of PTSD: A Placebo-Controlled Randomized Clinical TrialStatus: , Estimated PCD: 2024-05-01
Product
CBDClinical trial
Imaging Traumatic Stress and Alcohol Use Disorder With [18F]BavarostatStatus: Not yet recruiting, Estimated PCD: 2030-06-01
Product
BavarostatClinical trial
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era VeteransStatus: Recruiting, Estimated PCD: 2024-12-01
Product
PregnenoloneClinical trial
Pilot Study to Assess the Feasibility of Prazosin for Cannabis Use Disorder in Individuals With or Without Post-traumatic Stress DisorderStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Safety and Tolerability of Psilocybin in Post-Traumatic Stress DisorderStatus: Withdrawn, Estimated PCD: 2025-12-01
Clinical trial
IISPT2: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and MIStatus: Recruiting, Estimated PCD: 2027-12-31
Product
MDMA-ATClinical trial
Imaging the Neuroimmune System in PTSD With PETStatus: Active (not recruiting), Estimated PCD: 2023-05-30
Product
LipopolysaccharideClinical trial
Can Digital Health Technology Guide Medical Providers, in Treating Chronic Conditions With RIVER Ketamine Protocols Safely at Home?Status: Recruiting, Estimated PCD: 2028-10-01
Clinical trial
Wayne Warrior CAnnabis Research and Education: Cannabis and Behavioral HealthStatus: Not yet recruiting, Estimated PCD: 2030-12-31
Product
TetrahydrocannabinolClinical trial
Maximizing Efficacy of Goal-Directed Sedation to Reduce Neurological Dysfunction in Mechanically Ventilated Infants and Children StudyStatus: Recruiting, Estimated PCD: 2026-04-17
Product
DexmedetomidineClinical trial
Biological Signature and Safety of an Immunomodulatory Probiotic Intervention for Veterans With PTSDStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Lactobacillus rhamnosus GGClinical trial
Hyperbaric Oxygen Therapy vs. Pharmaceutical Therapy in Patients Suffering From Fibromyalgia That Was Induced by Emotional Trauma: Prospective, Randomized, Two Active Arms Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
Cymbalta + LyricaClinical trial
Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia SyndromeStatus: Recruiting, Estimated PCD: 2024-08-12
Product
PropranololClinical trial
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder: 5 Years Follow-up of the BACLOREA Randomized TrialStatus: Recruiting, Estimated PCD: 2025-09-03
Product
BaclofenClinical trial
Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic StressStatus: Recruiting, Estimated PCD: 2025-05-01
Product
iSWAB-DNAClinical trial
MDMA-assisted Massed Prolonged Exposure for PTSDStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Product
L-DOPADrug
VarlilumabClinical trial
The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal EffectsStatus: Recruiting, Estimated PCD: 2033-03-01
Clinical trial
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy AdultsStatus: Not yet recruiting, Estimated PCD: 2024-04-30
Product
SM-001Clinical trial
An Electrophysiological Predictor of SSRI Response in Veterans With PTSDStatus: Recruiting, Estimated PCD: 2025-03-30
Clinical trial
Cannabidiol as a Treatment for Alcohol Use Disorder Comorbid With Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2022-04-20
Drug
cannabidiolProduct
PlacebosClinical trial
Cannabidiol for Treating PTSD Symptoms and Neurocognitive Impairment in PTSD and PTSD Comorbid With TBI: A Placebo-controlled RCT With Neural-circuit Centered Precision Medicine Prediction of Response.Status: Recruiting, Estimated PCD: 2026-03-01
Clinical trial
A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSDStatus: Not yet recruiting, Estimated PCD: 2028-04-30
Product
OxytocinProduct
Saline nasal sprayClinical trial
Combining Topiramate and Prolonged Exposure for PTSD and Alcohol Use DisorderStatus: Completed, Estimated PCD: 2022-10-31
Product
topiramateClinical trial
Activation of the Endocannabinoid System and Cognition (Effekte Einer Akuten Aktivierung Des Cannabinoid-Systems Auf Kognitive Funktionen)Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
Kappa Opioid Receptor Antagonism for the Treatment of Alcohol Use Disorder (AUD) and Comorbid Post-Traumatic Stress Disorder (PTSD)Status: Terminated, Estimated PCD: 2022-05-02
Product
Buprenex + VivitrolClinical trial
Pain Multidisciplinar Intervention Effect in Major Trauma Patients. Does it Improve the Quality of Life?Status: Recruiting, Estimated PCD: 2024-04-01
Product
ParacetamolProduct
IbuprofenProduct
TramadolProduct
MorphineClinical trial
A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. VeteransStatus: Not yet recruiting, Estimated PCD: 2029-10-01
Clinical trial
Lofexidine Combined With Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder (PTSD) and Opioid Use Relapse in VeteransStatus: Recruiting, Estimated PCD: 2024-11-30
Product
LofexidineClinical trial
Effects of THC on Retention of Memory for Fear Extinction Learning in PTSD: R33 StudyStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Placebo-Controlled, Triple-Blind, Randomized Crossover Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)Status: Completed, Estimated PCD: 2018-11-01
Product
High THC cannabisProduct
High CBD cannabisProduct
THC/CBD cannabisProduct
Placebo cannabisClinical trial
Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder: A Pilot StudyStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Pilot Test of Intranasal Oxytocin as an Enhancer of Brief Couples Therapy for PTSDStatus: Completed, Estimated PCD: 2022-09-30
Clinical trial
A Preliminary Trial of Safety and Feasibility of Ketamine-assisted Psychotherapy in Adolescents With Posttraumatic Stress-disorderStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
Can Blocking the Orexin System Enhance Sleep's Benefits to Therapeutic Exposure for PTSD?Status: Completed, Estimated PCD: 2021-05-17
Product
suvorexantClinical trial
Assisted Animal Therapy in a French Intensive Care Unit (ICU): An Open Randomized StudyStatus: Terminated, Estimated PCD: 2022-08-24
Product
Nasal swab samplingProduct
Rectal swabClinical trial
Posttraumatic Stress Disorder (PTSD) Treatment: Using Ketamine to Enhance Memory Reconsolidation and Extinction of Overgeneralized Fear in Individuals Diagnosed With PTSDStatus: Recruiting, Estimated PCD: 2030-08-01
Clinical trial
The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories: A Model to Understand the Development of Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2020-12-31
Clinical trial
A Randomized, Double Blind, Placebo-controlled Study of the Effects of Stellate Ganglion Block on Neural Activity and Symptoms in Participants With Post-traumatic Stress DisorderStatus: Recruiting, Estimated PCD: 2025-06-10
Product
BupivacaineClinical trial
A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and BurnoutStatus: Active (not recruiting), Estimated PCD: 2024-03-30
Product
Active placeboClinical trial
Open-label Pimavanserin 34mg at Bedtime for 6 Weeks for Insomnia in Veterans With Post-traumatic Stress Disorder: Proof of Concept StudyStatus: Withdrawn, Estimated PCD: 2023-12-15
Product
PimavanserinClinical trial
Progesterone Treatment in Reducing Trauma and Alcohol Induced Craving in Individuals Diagnoses With Alcohol Dependence (AD) and Post-tramatic Stress Disorder (PTSD).Status: Completed, Estimated PCD: 2021-09-08
Product
ProgesteroneClinical trial
Silexan in the Treatment Of Posttraumatic Stress Disorder (STOP) TrialStatus: Not yet recruiting, Estimated PCD: 2027-02-28
Product
SilexanClinical trial
Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury From Special Forces Undercover UnitsStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Clinical trial
Evaluation of the Efficacy of a Herbal Supplement in the Prevention of Treatment of Post-traumatic Stress Disorder Versus Placebo (PHYTéS Study)Status: Completed, Estimated PCD: 2018-09-01
Product
aleozenClinical trial
FAAH Availability in Psychiatric Disorders: A PET StudyStatus: Terminated, Estimated PCD: 2021-06-30
Product
[11C]MK-3168Clinical trial
A Retrospective Chart Review of Patients Undergoing Ketamine Infusions at the Canadian Rapid Treatment Center of ExcellenceStatus: , Estimated PCD: 2023-12-01
Clinical trial
The Effects of MDMA on Prefrontal and Amygdala Activation in Posttraumatic Stress DisorderStatus: Withdrawn, Estimated PCD: 2028-01-01
Product
NiacinClinical trial
Repurposing Low-Dose Clonidine for PTSD in VeteransStatus: Recruiting, Estimated PCD: 2024-07-01
Product
ClonidineClinical trial
Neurosteroids in PTSD - Biomarkers to TherapeuticsStatus: Terminated, Estimated PCD: 2020-11-16
Product
DHEAClinical trial
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress DisorderStatus: Recruiting, Estimated PCD: 2025-12-01
Product
Brexanolone